<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-116153</identifier>
<setSpec>1887-8571</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Positive assessment of drugs: 2nd quarter 2013</dc:title>
<dc:description xml:lang="en">Medications are reviewed and evaluated by the Spanish Agency of Medicines and Health Products made &amp;#8203;&amp;#8203;public in the second quarter of 2013, and considered of greatest interest to the clinician. It is positive technical opinions that are pre-authorization and placing on the market of the product (AU)</dc:description>
<dc:creator>González Alfonso, M</dc:creator>
<dc:creator>García Luque, A</dc:creator>
<dc:creator>Puerro Vicente, M</dc:creator>
<dc:creator>Prats Olivan, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se reseñan los medicamentos ya evaluados por la Agencia Española de Medicamentos y Productos Sanitarios hechos públicos en el segundo trimestre de 2013, y considerados de mayor interés para el profesional sanitario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento (AU)</dc:description>
<dc:source>Sanid. mil;69(3): 206-209, sept. 2013.</dc:source>
<dc:identifier>ibc-116153</dc:identifier>
<dc:title xml:lang="es">Evaluación positiva de medicamentos: 2º Trimestre 2013</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d22172</dc:subject>
<dc:subject>^d24613</dc:subject>
<dc:subject>^d4403</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d33003</dc:subject>
<dc:subject>^d33276</dc:subject>
<dc:subject>^d3936</dc:subject>
<dc:type>article</dc:type>
<dc:date>201309</dc:date>
</metadata>
</record>
</ibecs-document>
